Basal insulin in China: Current status and update on weekly preparation
10.3760/cma.j.cn311282-20240102-00003
- VernacularTitle:中国基础胰岛素临床应用现状、展望及其周制剂研发进展
- Author:
Jian LI
1
;
Kun YANG
;
Tianpei HONG
Author Information
1. 北京大学第三医院内分泌科，北京 100191
- Keywords:
Basal insulin;
Clinical practice;
Weekly preparation;
Adherence;
Diabetes
- From:
Chinese Journal of Endocrinology and Metabolism
2024;40(11):989-993
- CountryChina
- Language:Chinese
-
Abstract:
Basal insulin is essential for blood glucose management. However, its clinical application in China faces multiple challenges such as delayed initiation, low initial dosage, and inadequate dose adjustments. The BEYOND series of studies were conducted to provide an evidence-based basis for optimizing basal insulin use in China. Moreover, basal insulin is advancing towards weekly preparation. Phase Ⅲ clinical trials have demonstrated that weekly basal insulin is both effective and safe, and its reduced injection frequency may help address the challenges associated with basal insulin use in China.
